New approaches in the management of fulminant hepatic failure.
D000328:Adult; D000818:Animals; D001120:Arginine / Q000627:therapeutic use; D005078:Exchange Transfusion, Whole Blood; D005112:Extracorporeal Circulation; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D013006:Growth Hormone / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008099:Liver; D009355:Neomycin / Q000627:therapeutic use; D010215:Papio; D010227:Parabiosis; D010477:Perfusion; D014812:Vitamin K / Q000627:therapeutic use
D005938:Glucocorticoids; D014812:Vitamin K; D013006:Growth Hormone; D001120:Arginine; D009355:Neomycin; D005947:Glucose